{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:35:50Z","timestamp":1791524150281,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.vaccine.2008.05.045","type":"journal-article","created":{"date-parts":[[2008,6,11]],"date-time":"2008-06-11T09:39:14Z","timestamp":1213177154000},"page":"3818-3826","source":"Crossref","is-referenced-by-count":43,"title":["Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073"],"prefix":"10.1016","volume":"26","author":[{"given":"P.","family":"Fytili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.N.","family":"Dalekos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Schlaphoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.V.","family":"Suneetha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sarrazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Zauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Zachou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Klade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cornberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 7","key":"10.1016\/j.vaccine.2008.05.045_bib1","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1099\/0022-1317-81-7-1631","article-title":"Replication of hepatitis C virus","volume":"81","author":"Bartenschlager","year":"2000","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.045_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1089-3261(02)00065-X","article-title":"Hepatitis C virus genetic variability: pathogenic and clinical implications","volume":"7","author":"Pawlotsky","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.045_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection","volume":"5","author":"Rehermann","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.045_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1074-7613(00)80044-8","article-title":"Analysis of a successful immune response against hepatitis C virus","volume":"10","author":"Cooper","year":"1999","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.vaccine.2008.05.045_bib5","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","article-title":"Analysis of successful immune responses in persons infected with hepatitis C virus","volume":"191","author":"Lechner","year":"2000","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.vaccine.2008.05.045_bib6","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection","volume":"197","author":"Shoukry","year":"2003","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.045_bib7","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection","volume":"194","author":"Thimme","year":"2001","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.045_bib8","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.4049\/jimmunol.169.6.3447","article-title":"Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection","volume":"169","author":"Wedemeyer","year":"2002","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.05.045_bib9","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1128\/JVI.79.12.7860-7867.2005","article-title":"T cells with a CD4+ CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection","volume":"79","author":"Boettler","year":"2005","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.045_bib10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hep.20856","article-title":"Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection","volume":"42","author":"Spangenberg","year":"2005","journal-title":"Hepatology"},{"issue":"7053","key":"10.1016\/j.vaccine.2008.05.045_bib11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nature04081","article-title":"Prospects for a vaccine against the hepatitis C virus","volume":"436","author":"Houghton","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.045_bib12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/75063","article-title":"Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C","volume":"6","author":"Takaki","year":"2000","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.045_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2249.2002.01840.x","article-title":"Cellular immune responses against hepatitis C virus: the evidence base 2002","volume":"128","author":"Ward","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"20","key":"10.1016\/j.vaccine.2008.05.045_bib14","doi-asserted-by":"crossref","first-page":"12979","DOI":"10.1128\/JVI.79.20.12979-12988.2005","article-title":"Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy","volume":"79","author":"Lauer","year":"2005","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.045_bib15","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1086\/315450","article-title":"Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C","volume":"181","author":"Gruner","year":"2000","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.045_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/jhep.2001.21162","article-title":"Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection","volume":"33","author":"Chang","year":"2001","journal-title":"Hepatology"},{"issue":"20","key":"10.1016\/j.vaccine.2008.05.045_bib17","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1016\/j.vaccine.2006.03.009","article-title":"Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects","volume":"24","author":"Firbas","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.045_bib18","first-page":"251A","article-title":"Immunization with the therapeutic hepatitis C virus (HCV) peptide vaccine IC41 in 66 chronic hepatitis C non-responder patients","volume":"40","author":"Manns","year":"2004","journal-title":"Hepatology"},{"issue":"37\u201338","key":"10.1016\/j.vaccine.2008.05.045_bib19","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1016\/j.vaccine.2007.06.026","article-title":"Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients","volume":"25","author":"Schlaphoff","year":"2007","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2008.05.045_bib20","doi-asserted-by":"crossref","first-page":"11392","DOI":"10.1128\/JVI.75.23.11392-11400.2001","article-title":"Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells","volume":"75","author":"Wedemeyer","year":"2001","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.045_bib21","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1084\/jem.20041058","article-title":"Heterologous T cell immunity in severe hepatitis C virus infection","volume":"201","author":"Urbani","year":"2005","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.vaccine.2008.05.045_bib22","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1172\/JCI119778","article-title":"Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus","volume":"100","author":"Chang","year":"1997","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.045_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/gut.2005.072231","article-title":"Relation between viral fitness and immune escape within the hepatitis C virus protease","volume":"55","author":"Soderholm","year":"2006","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.045_bib24","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/j.gastro.2006.02.015","article-title":"Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin","volume":"130","author":"Berg","year":"2006","journal-title":"Gastroenterology"},{"issue":"24","key":"10.1016\/j.vaccine.2008.05.045_bib25","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.87.24.9524","article-title":"Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis","volume":"87","author":"Kato","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.045_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.152.1.163","article-title":"Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains","volume":"152","author":"Parker","year":"1994","journal-title":"J Immunol"},{"issue":"13","key":"10.1016\/j.vaccine.2008.05.045_bib27","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/JVI.76.13.6586-6595.2002","article-title":"Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge","volume":"76","author":"Major","year":"2002","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.045_bib28","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1086\/496889","article-title":"Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model","volume":"192","author":"Prince","year":"2005","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2008.05.045_bib29","doi-asserted-by":"crossref","first-page":"11094","DOI":"10.1128\/JVI.00912-06","article-title":"Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection","volume":"80","author":"Gaudieri","year":"2006","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.045_bib30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/hep.21049","article-title":"Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution","volume":"43","author":"Neumann-Haefelin","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.045_bib31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/hep.21702","article-title":"Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution","volume":"46","author":"Timm","year":"2007","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.vaccine.2008.05.045_bib32","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1084\/jem.20042323","article-title":"Structural and kinetic basis for heightened immunogenicity of T cell vaccines","volume":"201","author":"Chen","year":"2005","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.045_bib33","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.20050121","article-title":"Cellular immune selection with hepatitis C virus persistence in humans","volume":"201","author":"Cox","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.05.045_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/3-540-32636-7_5","article-title":"The privacy of T cell memory to viruses","volume":"311","author":"Welsh","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.045_bib35","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1172\/JCI27804","article-title":"Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity","volume":"116","author":"Cornberg","year":"2006","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.045_bib36","first-page":"1143","article-title":"Defining the directionality and quality of influenza virus-specific CD8 T cell cross-reactivity in individuals infected with hepatitis C virus","volume":"118","author":"Kasprowicz","year":"2008","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.vaccine.2008.05.045_bib37","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1128\/JVI.76.12.6104-6113.2002","article-title":"Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities","volume":"76","author":"Lauer","year":"2002","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.045_bib38","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1053\/j.gastro.2004.06.015","article-title":"High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection","volume":"127","author":"Lauer","year":"2004","journal-title":"Gastroenterology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08006038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08006038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:45:12Z","timestamp":1684439112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08006038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":38,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0264410X08006038"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.05.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}